Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

TP53 Mutation in Waldenstrom Macroglobulinemia

Stephanie Poulain, Christophe Roumier, MD, Elisabeth Bertrand, Aline Renneville, MD, Sabine Tricot, Aurelie Caillault Venet, Sandrine Geffroy, PhD, Morgan Nudel, Charles Herbaux, MD, Stéphanie Guidez, Claude Preudhomme, MD PhD, Xavier Leleu

Blood (2016) 128 (22): 4092.

https://doi.org/10.1182/blood.V128.22.4092.4092

Published: 2016

Journal Articles

De Novo and Secondary Acute Myeloid Leukemia, Real World Data on Outcomes from the French Nord-Pas-De-Calais Picardie Acute Myeloid Leukemia Observatory

Loïc Renaud, Olivier Nibourel, PharmD, PhD, Celine Berthon, Christophe Roumier, Céline Rodriguez, Cecile Frimat, Catherine Roche-Lestienne, Aline Renneville, MD, Bruno Quesnel, MD PhD, Claude Preudhomme, MD PhD

Blood (2016) 128 (22): 4013.

https://doi.org/10.1182/blood.V128.22.4013.4013

Published: 2016

Journal Articles

Mutational Analysis of MDS and AML Occurring after Treatment for Acute Promyelocytic Leukemia (APL). a Report of 9 Cases

Philippe Attias, Aline Renneville, MD, Xavier Thomas, MD PhD, Cecile Bally, Sandrine Hayette, Hassan Farhat, MD, Virginie Eclache, MD, Alice Marceau, Bruno Cassinat, PharmD, PhD, Jean Feuillard, MD PhD Pr, Christine Terré, PharmD, PhD, Eric Delabesse, PharmD, PhD, Sophie Park, MD PhD, Julie Lejeune, Sylvie Chevret, MD PhD, Lionel Ades, MD PhD, Claude Preudhomme, MD PhD, Pierre Fenaux, MD PhD

Blood (2016) 128 (22): 2861.

https://doi.org/10.1182/blood.V128.22.2861.2861

Published: 2016

Journal Articles

The B7-H3 Protein In Acute Myeloid Leukemia

Thomas Guéry, MD, Christophe Roumier, MD, Céline Berthon, MD, PhD, Pascale Lepelley, MD, Aline Renneville, MD, PhD, Olivier Nibourel, Florent Dumezy, MD, Valérie Soenen, MD, PhD, Catherine Roche, PhD, Claude Preudhomme, MD, PhD, Bruno Quesnel, MD, PhD

Blood (2013) 122 (21): 2620.

https://doi.org/10.1182/blood.V122.21.2620.2620

Published: 2013

Journal Articles

Minimal Residual Disease Monitoring In t(8;21) Acute Myeloid Leukemia Based On RUNX1-RUNX1T1 Fusion Quantification On Genomic DNA

Nicolas Duployez, Aline Renneville, MD, PhD, Olivier Nibourel, Alice Marceau-Renaut, Nathalie Helevaut, Aurélie Caillault, Celine Villenet, Karine Celli-Lebras, Nicolas Boissel, MD, PhD, Eric Jourdan, MD PhD, Herve Dombret, MD, PhD, Martin Figeac, PhD, Claude Preudhomme

Blood (2013) 122 (21): 1353.

https://doi.org/10.1182/blood.V122.21.1353.1353

Published: 2013

Journal Articles

Prognostic Value of TP53 Gene Mutations in Higher Risk MDS Treated with Azacitidine

Cecile Bally, Lionel Ades, MD, PhD, Aline Renneville, MD, Claude Preudhomme, Marie-Joelle Mozziconacci, MD, PhD, Hugues de The, MD, PhD, Jacqueline Lehmann-Che, Pierre Fenaux, MD, PhD

Blood (2012) 120 (21): 1706.

https://doi.org/10.1182/blood.V120.21.1706.1706

Published: 2012

Journal Articles

Genome Wide SNP Array (SNPa) Analysis Reveals Clonal Evolution During Clinical Course in Waldenstrom's Macroglobulinemia (WM)

Stephanie Poulain, Christophe Roumier, Charles Herbaux, MD, Aline Renneville, MD, Elisabeth Bertrand, Agnes Daudignon, Sabine Tricot, MD, Valérie Soenen, Catherine Roche-Lestienne, Olivier Nibourel, Bruno Quesnel, MD, PhD, Claude Preudhomme, Patrick Duthilleul, Xavier Leleu, MD

Blood (2012) 120 (21): 297.

https://doi.org/10.1182/blood.V120.21.297.297

Published: 2012

Journal Articles

MYD88 L265P Mutation in Waldenstrom's Macroglogulinemia

Stephanie Poulain, Christophe Roumier, Audrey Decambron, Aline Renneville, MD, Charles Herbaux, MD, Elisabeth Bertrand, Sabine Tricot, MD, Agnes Daudignon, Sylvie Galiegue-Zouitina, Olivier Theisen, Nathalie Grardel, Valérie Soenen, Olivier Nibourel, Catherine Roche-Lestienne, Bruno Quesnel, Patrick Duthilleul, Claude Preudhomme, Xavier Leleu, MD, PhD

Blood (2012) 120 (21): 1307.

https://doi.org/10.1182/blood.V120.21.1307.1307

Published: 2012

Journal Articles

Incidence and Prognostic Value of TP53 Mutations in Lower Risk MDS with Del 5q.

Cecile Bally, Lionel Ades, MD, PhD, Aline Renneville, MD, Sophie Raynaud, Virginie Eclache, MD, Thomas Cluzeau, MD, PhD, Mathilde Hunault-Berger, MD, PhD, Aspasia Stamatoullas, MD, Christian Bastard, MD, Michaela Fontenay, MD, PhD, Marie-Joelle Mozziconacci, MD, PhD, Claude Preudhomme, Hugues de The, MD, PhD, Pierre Fenaux, MD, PhD, Jacqueline Lehmann-Che, PharmD, PhD

Blood (2012) 120 (21): 2809.

https://doi.org/10.1182/blood.V120.21.2809.2809

Published: 2012

Journal Articles

BCL2L10 (Bcl-B) Is Associated with Resistance to Azacitidine (AZA) in MDS and AML, and Is a Possible Therapeutic Target in AZA Resistant Patients

Thomas Cluzeau, MD, PhD, Guillaume Robert, Jean-Michel Karsenti, MD, Frederic Luciano, Alexandre Puissant, Faezeh Legrand, MD, PhD, Lionel Mannone, MD, Aline Renneville, MD, Claude Preudhomme, Pierre Fenaux, MD, PhD, Jill-Patrice Cassuto, MD, Sophie Raynaud, Nicolas Mounier, MD, PhD, Patrick Auberger, MD, PhD

Blood (2012) 120 (21): 701.

https://doi.org/10.1182/blood.V120.21.701.701

Published: 2012

Journal Articles

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Benedicte Deau, MD, Mathias Montveneur, MStud, Valérie Coiteux, MD, Aline Renneville, MD, Francoise Rigal-Huguet, MD, Eric Delabesse, MD, PhD, Michel Tulliez, MD, Dominique Bories, MD, PhD, Aude Charbonnier, MD, PhD, Marie-Joelle Mozziconacci, MD, PhD, Thibault Legay, MD, Eric Lippert, PhD, Francois-Xavier Mahon, MD, PhD, Delphine Rea, MD, PhD, Jean-Michel Cayuela, PhD, Shanti Amé, MD, Marie-Pierre Gaub, MD, Martine Gardembas, MD, Odile Blanchet, MD, Bruno Audhuy, MD, Agnès Buzyn, MD, PhD, Elisabeth Mac Intyre, MD, PhD, Anna-Lisa Andreoli, MD, Oumedaly Reman, Nathalie Contentin, MD, Christian Bastard, MD, Jean-Christophe Ianotto, MD, Valérie Ugo, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Said Brahimi, MD, Viviane Dubruille, Jean-Francois Brantus, MD, Mohamad Sobh, Pharm., M., Stephane Morisset, Stat., Claude Preudhomme, MD, PhD, Sandrine Hayette, PhD, Franck E Nicolini, MD, PhD

Blood (2010) 116 (21): 3378.

https://doi.org/10.1182/blood.V116.21.3378.3378

Published: 2010

Journal Articles

Prognostic Impact of Wilms Tumor 1 Single Nucleotide Polymorphism rs16754 In Older Patients with Acute Myeloid Leukemia

Aline Renneville, MD, Nicolas Boissel, MD, PhD, Nathalie Helevaut, Olivier Nibourel, Christine Terré, Cécile Pautas, Claude Gardin, Xavier Thomas, Pascal Turlure, Oumedaly Reman, Céline Berthon, Hervé Dombret, Sylvie Castaigne, MD, Claude Preudhomme

Blood (2010) 116 (21): 2701.

https://doi.org/10.1182/blood.V116.21.2701.2701

Published: 2010

Journal Articles

New Insights to the MLL Recombinome Including 8 Novel Partner Genes ACTN4, C2CD3, DCP1A, FLNA, LAMC3, LOC100128568, NRIP3, and TNRC18.

Claus Meyer, PhD, Eric Kowarz, PhD, Julia Hofmann, Thomas Fischer, Sara El Ashkar, Andrea Teigler-Schlegel, PhD, Brian Balgobind, MD, Thomas Burmeister, PhD, Etienne De Braekeleer, Eric Delabesse, PhD, Aline Renneville, MD, Theo Dingermann, PhD, Thomas Klingebiel, MD, Rolf Marschalek, PhD

Blood (2008) 112 (11): 2047.

https://doi.org/10.1182/blood.V112.11.2047.2047

Published: 2008

NARROW

TP53 Mutation in Waldenstrom Macroglobulinemia

De Novo and Secondary Acute Myeloid Leukemia, Real World Data on Outcomes from the French Nord-Pas-De-Calais Picardie Acute Myeloid Leukemia Observatory

Mutational Analysis of MDS and AML Occurring after Treatment for Acute Promyelocytic Leukemia (APL). a Report of 9 Cases

The B7-H3 Protein In Acute Myeloid Leukemia

Minimal Residual Disease Monitoring In t(8;21) Acute Myeloid Leukemia Based On RUNX1-RUNX1T1 Fusion Quantification On Genomic DNA

Prognostic Value of TP53 Gene Mutations in Higher Risk MDS Treated with Azacitidine

Genome Wide SNP Array (SNPa) Analysis Reveals Clonal Evolution During Clinical Course in Waldenstrom's Macroglobulinemia (WM)

MYD88 L265P Mutation in Waldenstrom's Macroglogulinemia

Incidence and Prognostic Value of TP53 Mutations in Lower Risk MDS with Del 5q.

BCL2L10 (Bcl-B) Is Associated with Resistance to Azacitidine (AZA) in MDS and AML, and Is a Possible Therapeutic Target in AZA Resistant Patients

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Prognostic Impact of Wilms Tumor 1 Single Nucleotide Polymorphism rs16754 In Older Patients with Acute Myeloid Leukemia

New Insights to the MLL Recombinome Including 8 Novel Partner Genes ACTN4, C2CD3, DCP1A, FLNA, LAMC3, LOC100128568, NRIP3, and TNRC18.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only